Last reviewed · How we verify

NCT05244967: ESTIMATE

Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility

Recruiting now Last updated 29 November 2023
What this trial tests

trial testing vaginal swab in Sexually Transmitted Infection in 533 participants. Currently enrolling.

Timeline
11 November 2020
Primary endpoint
31 December 2028
30 June 2029

Quick facts

Lead sponsorUniversity of Luebeck
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment533
Start date11 November 2020
Primary completion31 December 2028
Estimated completion30 June 2029
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Luebeck

Who can join

Adults 18 to 22, female only, with Sexually Transmitted Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A longitudinal study to investigate the prevalence of sexually transmitted infections among young women and determine the role of the female genital tract microbiome in fertility

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of vaginal swab

Trials testing the same drug.

Other recruiting trials for Sexually Transmitted Infection

Currently open trials in the same condition.

Other University of Luebeck trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05244967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing